rss

Профиль компании

Финансовые компании

Блог компании DayTraderClub | Америка сегодня. Рынок недвижимости, данные по безработице и производственная активность.

Количество новых строительств и выданных разрешений продолжают увеличиваться. Сегодня в данных аналитики ожидают значение 1,255 млн. по объему нового строительства и 1,256 млн. по выданным разрешениям:
Америка сегодня. Рынок недвижимости, данные по безработице и производственная активность.


В заявках на пособие по безработице прогнозируют продолжение тенденции уменьшения и показатель на этой неделе ожидают на отметке 240 тысяч и ниже:
Америка сегодня. Рынок недвижимости, данные по безработице и производственная активность.


В данных по производственной активности от федерального банка Филадельфии ожидается коррекция к значению 30, показатель находится на своих максимумах:
Америка сегодня. Рынок недвижимости, данные по безработице и производственная активность.


Все новости: 
Америка сегодня. Рынок недвижимости, данные по безработице и производственная активность.
Данные: DTC News, Briefing, Interactive, Economics, Public Sources

  Antero Resources upgraded to Buy from Neutral at Guggenheim  (23.88)
avatar

Daytrader

 
  Alarm.com target raised to $29 at Stifel  (30.63)Stifel raises their ALRM tgt to $29 from $27, reiterates Hold.  The firm notes that After the close on Wednesday, Alarm.com posted solid results for 4Q16 that included total revenue and adjusted EBITDA coming in ahead of management's guidance/Stifel estimates. Specifically, total revenue of $69.8M topped their expectations by over $5M; however, the vast majority of the beat was once again driven by hardware revenue of $22.9M (vs. our estimate of $18.2M). While growth in subscribers and modest improvements in ARPU helped drive subscription revenue up a respectable 21.2% Y/Y to $46.9M, they note this marks the fifth consecutive quarter that organic recurring revenue growth has decelerated. Given the healthy gross margin profile of this revenue stream, as well as leverage across all three lines of the P&L, Alarm.com drove adjusted EBITDA of $14.3M that nicely topped their $11.7M estimate.
avatar

Daytrader

 
  Oasis Petroleum upgraded to Buy from Neutral at Guggenheim  (13.29)
avatar

Daytrader

 
  Oracle upgraded to Overweight from Neutral at JP Morgan  (43.05)
avatar

Daytrader

 Delta Air Lines upgraded to Outperform from In Line at Evercore ISI  (47.19)
avatar

Daytrader

 
  United Continental downgraded to In Line from Outperform at Evercore ISI  (68.17)
avatar

Daytrader

 
  Columbia Banking upgraded to Buy from Neutral at DA Davidson  (39.16)
avatar

Daytrader

 
  Alliant Energy initiated with a Neutral at UBS  (39.58)
avatar

Daytrader

 
  Garrison Capital downgraded to Hold from Buy at Wunderlich  (9.96)
avatar

Daytrader

 
  Williams-Sonoma downgraded to Market Perform from Outperform at William Blair  (48.12)
avatar

Daytrader

 
  Asian Markets Close: Nikkei +0.1%, Hang Seng +2.1%, Shanghai +0.8%

Equity indices in the Asia-Pacific region ended Thursday on a higher note. Japan's Nikkei (+0.1%) underperformed, but still eked out a slim gain after the Bank of Japan made no changes to its policy stance. The central bank did make upbeat comments about reaching the 2.0% inflation target in the longer run. Separately, the People's Bank of China raised its short-term repurchase rates after yesterday's fed funds rate hike from the Federal Reserve.

  • In economic data:
    • Australia's February Employment Change -6,400 (expected 16,000; last 13,500) and February Unemployment Rate 5.9% (expected 5.7%; last 5.7%). February Participation Rate held at 64.6%, as expected.
    • New Zealand's Q4 GDP +0.4% quarter-over-quarter (expected 0.7%; last 0.8%); +2.7% year-over-year (consensus 3.1%; last 3.3%). Q4 GDP Expenditure +0.2% quarter-over-quarter (expected 0.6%; last 0.9%)
    • Hong Kong's February Unemployment Rate held at 3.3%, as expected

---Equity Markets---

  • Japan's Nikkei added 0.1%. Furukawa Electric, Minebea Mitsumi, Komatsu, SUMCO, Hino Motors, Okuma, Softbank, Hitachi Construction, and Yamaha advanced between 1.4% and 5.1%. On the downside, Toshiba fell 3.2% into the neighborhood of its low from February.
  • Hong Kong's Hang Seng rallied 2.1% to settle just below its high from September. China Unicom Hong Kong led the way with a 5.5% spike while financials like China Life Insurance, Bank of East Asia, ICBC, Bank of China, Ping An Insurance, and Hang Seng Bank posted gains between 1.7% and 3.6%.
  • China's Shanghai Composite advanced 0.8%. Tongling Jingda Special Magnet Wire, Sichuan Minjiang Hydropower, Shanghai Chinafortune, Anhui Heli, and Kangxin New Materials added between 3.9% and 4.6%.
  • India's Sensex rose 0.6%, posting a fresh record close. Growth-sensitive names like Adani Ports, Tata Steel, Bajaj Auto, and Tata Motors climbed between 1.5% and 4.7%. Tech consultants like Infosys and Wipro added 1.6% and 1.2%, respectively.

---FX---

  • USDJPY +0.1% to 113.48
  • USDCNY -0.1% to 6.9016
  • USDINR +0.4% to 65.470
avatar

Daytrader

 
  Lending Club upgraded to Buy from Neutral at Guggenheim  (5.35)
avatar

Daytrader

 
  Instructure upgraded to Strong Buy from Outperform at Raymond James  (23.15)
avatar

Daytrader

 
  Entergy upgraded to Outperform from Market Perform at Wells Fargo  (75.18)
avatar

Daytrader

 
  Syndax Pharmaceuticals initiated with a Outperform at FBR & Co.; tgt $27  (14.72)FBR & Co. initiates SNDX with a Outperform and price target of $27. Syndax is a biotechnology company that has received breakthrough designation from the FDA for its lead product candidate, entinostat, which is in Phase III development for the treatment of hormone receptor positive (HR+) breast cancer. Syndax also has several immuno-oncology collaborations with major pharma/biotech companies for the development of combination therapy with their checkpoint inhibitors plus entinostat for other cancer indications. In addition, Syndax is developing a next-generation tumor microenvironment modulating agent (SNDX-6352) that could potentially have a broad indication in cancer therapy. The company is capitalized into mid 2018, and firm believes there are several catalysts in 2017 that could move the stock higher.
avatar

Daytrader

 
  Evoke Pharma target raised to $9 from $6 at Rodman & Renshaw after the Q4 print  (3.16)
avatar

Daytrader

 
  Snap initiated with a Sell at MoffettNathanson; tgt $15  (20.77)
avatar

Daytrader

 
  Clean Harbors upgraded to Outperform from Perform at Oppenheimer  (55.74)
avatar

Daytrader

 YPF Soc. Anonima upgraded to Buy from Neutral at UBS  (22.28)
avatar

Daytrader

 
  Synaptics upgraded to Outperform from Market Perform at Northland Capital  (49.55)
avatar

Daytrader

 Gentherm upgraded to Buy at Argus  (37.45)
avatar

Daytrader

 
  Tyson Foods downgraded to Hold at Argus  (63.10)
avatar

Daytrader

 
  Williams-Sonoma: Color on Quarter  (48.12)
  • RBC stays at sector perform, but does raise its PT to $53 from $50. The firm believes sales were below expectations due to continued competitive pressures and a tough sales environment. The firm notes that while the PB brands (~60% of sales) were the primary source of underperformance, even the younger/faster growing West Elm slowed somewhat.
  • Telsey Advisory maintains its Market Perform rating; tgt still at $51. The firm notes that Q4 EPS exceeded expectations and provided 2017 guidance in-line w/ expectations.The firm believes Williams-Sonoma is managing profitability well in a very competitive retail climate. However, the company's outlook embeds sales growth at Pottery Barn turning positive in 2H17 and the firm is concerned this could take longer to achieve.
  • Wolfe Research stays at Peer Perform. The firm notes WSM continues to show inventory discipline (their IM Spread positively inflected at the end of 1Q16 for the first time in 20 quarters). The firm continues to expect sales growth to outpace inventory growth in 2H, thereby supporting margins, as evidenced by this quarter's better-than-expected GM.

WSM is currently up almost 2% around the 49 level in trading pre-market. 

avatar

Daytrader

 Index Changes Reminder: The following changes will take place this morning ahead of the bell in the S&P 500, MidCap 400 and SmallCap 600
  • S&P MidCap 400 constituent Synopsys (SNPS) will replace Harman (HAR) in the S&P 500, S&P SmallCap 600 constituent GEO Group (GEO) will replace SNPS in the S&P MidCap 400, and Coca-Cola Bottling Co. (COKE) will replace GEO in the S&P SmallCap 600.
  • Orthofix (OFIX) will replace Tangoe (TNGO) in the S&P SmallCap 600.
avatar

Daytrader

 
  Conatus Pharma target raised to $9 at Stifel  (4.91)Stifel raises their CNAT tgt to $9 from $7 as they believe the recent Novartis (NVS) collaboration provides a floor in CNAT shares as the company works through what should be an admittedly quiet FY17 until numerous P2b data catalysts related to the ENCORE development program begin to materialize in FY18.
avatar

Daytrader

 Early premarket gappers

Gapping up:

  • GALE +15.3%, SKLN +13%, GPRO +11%, XCO +9.4%, ALRM +9%, FRSH +8.7%, JASO +8%, ORCL +6.3%, CLRB +6.2%, IDRA +6%, YRD +5.5%
  • DG +4.4%, ITEK +4.3%, BBVA +3.9%, RMTI +3.6%, SAN +3.3%, CPRX +3.2%, SYNC +3.2%, FRO +3.1%, RYAAY +3.1%, AG +3%, ING +2.7%, SWC +2.7%
  • RTK +2.7%, TSLA +2.5%, SSRI +2.5%, DO +2.3%, AEM +2.3%, DB +2.2%, GG +1.9%, BBL +1.9%, CALL +1.9%, TDG +1.8%, HAL +1.8%, CLF +1.8%, WSM +1.8%
  • BKS +1.7%, SPWR +1.7%, FCX +1.6%, BHP +1.6%, SAP +1.5%, CS +1.5%, PBR +1.4%, EQC +1.3%, VALE +1.3%, VRX +1.3%, EVOK +1.3%, GOLD +1.1%
  • PAAS +0.9%, CVRS +0.7%, CNAT +0.6%

Gapping down:

  • IPI -15.5%, ARTX -14.6%, GES -12.5%, INO -9.2%, AVID -6.5%, SAEX -5.8%, PEN -4.1%, TROV -2.9%, BIIB -1.9%, JBL -1.8%
  • BCEI -1.7%, GV -1.7%, HMY -1.6%, SDRL -1.4%, ELF -1.3%, KNDI -1.2%, QGEN -1.1%, M -0.8%, TEVA -0.8%, OR -0.8%, CCL -0.6%
avatar

Daytrader

 
  Jabil Circuit target raised to $26 at Stifel  (26.98)Stifel raises their JBL tgt to $26 from $23 following the Q2 print. The firm also noted the large exposure to Apple (20%+) and volatility around product cycles, adds risk and could keep multiples toward the low-end of the peer group. Firm also feels the $3 EPS tgt by FY19 seems achievable.
avatar

Daytrader

 
  GoPro target lowered to $9 at Stifel — GPRO gets serious about expense management; Confirms solid 1Q sales  (7.35)Stifel lowers their GPRO tgt to $9 from $10 as they feel GPRO is showing a new level of commitment to profitability and cash mgmt. Firm is encouraged by new discipline and solid 1Q pre-announced results. Such sharp expense reduction, however, raises questions about fundamental impact including the demand consequence of lower marketing and the risk to product launch execution for a company with a poor recent track record. With their concerns about category sustainability, nearly half of full-year 2017 rev dependent of FY4Q and ongoing execution risk, they remain comfortable at Hold. Our 12 month target goes from $10 to $9 reflecting the same 1.0X TEV/Sales multiple but a more accurate assessment of net cash balances (forward 4Q avg. now 1Q-4Q vs. 3Q-2Q).
avatar

Daytrader

 
  Jabil Circuit upgraded to Buy at Needham; tgt $30  (26.98)Needham upgrades JBL to Buy from Hold and sets target price at $30. Overall, firm sees JBL as being in the early stages of seeing at least moderate growth in a number of non-AAPL areas within its business. Importantly, they believe the mix optimization within EMS is near completion, and this should bring steadier, more profitable results while growth in DMS is being sourced by consumer lifestyle, healthcare and packaging (all in addition to expected Apple (AAPL) momentum into/ through 2018). As they step back and consider that their comfort has improved in terms of JBL's direction and profit trajectory, firm observes that the current P/E multiple appears to be low and seems to offer a solid opportunity to investors
avatar

Daytrader

 
  On The Wires
  • AcelRx Pharmaceuticals (ACRX) will present data from the DSUVIA (sufentanil sublingual tablet, 30 mcg) clinical program at two upcoming medical meetings. On March 16, 2017, during the annual meeting of the American Academy of Pain Medicine, AcelRx will present a poster from SAP101 comparing the pharmacokinetics of DSUVIA to that of an intravenous (IV) infusion of Sufenta (sufentanil citrate injection, 30 mcg). On March 21, 2017, AcelRx will present safety and efficacy findings from SAP302 during the International Symposium on Intensive Care and Emergency Medicine being held in Brussels. SAP302 was an open-label Phase 3 trial conducted in 76 adult patients who present to the emergency department with moderate-to-severe acute pain associated with trauma or injury.
  • Glaukos Corporation (GKOS) announced that the Current Procedural Terminology Editorial Panel of the American Medical Association has granted five-year extensions to three Category III CPT codes that describe insertion of aqueous drainage devices into the anterior chamber of the eye using Micro-Invasive Glaucoma Surgery.
  • Companhia Paranaense de Energia (ELP) hereby informs that the Executive Board of the Brazilian Electricity Regulatory Agency — Aneel denied Copel Geração e Transmissão S.A.'s request to reconsider order 1580/2016, which rejected the administrative application for the recognition of exclusions of liability for the delay in the Colíder Hydroelectric Power Plant implementation schedule and the exemption of charges and regulatory, contractual or commercial penalties. Considering that the plant's startup schedule was impacted by government actions and force majeure events that occurred during the project's implementation, the co will take this matter to court with the certainty that Agency's decision will be overturned. The startup of the first generation unit is scheduled for Dec 2017 and the third and last generation unit is scheduled to begin operating in April 2018. The co also states that Copel GeT participated in the offer to reduce the Electricity Trading Contracts in the Regulated Environment — CCEARs related to the annual processing of the Mechanism for Compensation of Surpluses and Deficits — MCSD of New Energy for the product from Jan 1 to Dec 2017 and, as a result, the Colíder HPP obtained a full reduction of its contracts (125 average-MW) for 2017.
avatar

Daytrader

Сегодня отрабатываем вчерашние фомсы)))
avatar

Игорь Т

 
  Exelixis initiated with a Perform at Oppenheimer  (22.80)
avatar

Daytrader

 
  Seattle Genetics initiated with a Perform at Oppenheimer  (67.28)
avatar

Daytrader

 
  Tivity Health initiated with a Buy at SunTrust; tgt $35  (27.85)
avatar

Daytrader

 
  TrovaGene downgraded to Hold at Maxim Group  (1.75)Maxim Group downgrades TROV to Hold from Buy after reported essentially burning just under $10M in the quarter and ending the year with $38M in cash. Firm's current model is focused on Trovagene the diagnostics company and we will need to re-evaluate the company given the new focus on developing diagnostic-based therapeutics. As such, for the moment they are lowering rating to Hold while they evaluate the new strategic direction.
avatar

Daytrader

 
  Inovio Pharma upgraded to Buy at Maxim Group; tgt $10  (6.87)Maxim Group upgrades INO to Buy from Hold and sets target price at $10 with a combination of moving closer to the pivotal study in cervical dysplasia and multiple earlier stage programs moving forward with more significant data points coming throughout 2017.
avatar

Daytrader

 
  Blackhawk Network initiated with a Buy at SunTrust; tgt $44  (35.50)
avatar

Daytrader

 
  Dermira initiated with a Underperform at Raymond James  (36.16)
avatar

Daytrader

 
  Zoetis initiated with a Buy at Craig Hallum; tgt $65  (54.28)
avatar

Daytrader

 
  Masimo downgraded to Neutral from Overweight at Piper Jaffray  (96.47)
avatar

Daytrader

 
  European Markets Update: CAC +0.8%, DAX +1.0%, FTSE +1.0%

Major European indices trade higher across the board with Italy's MIB (+1.7%) showing relative strength. The upbeat disposition comes ahead of the release of the latest policy statement from the Bank of England, which is not expected to upset the current state of affairs. Elsewhere, the Swiss National Bank maintained its key rate at -0.75%, as expected. Also of note, Dutch Prime Minister Mark Rutte's People's Party for Freedom and Democracy received the most votes, but the party will now have 33 seats in the House of Representatives, down from 41 won in the 2012 election. Geert Wilders' PVV came in second, securing 20 seats. On a separate note, French BFM TV reported that one person was slightly injured in an explosion while opening an envelope at Paris offices of the International Monetary Fund. This comes after a package with explosives was found outside the German finance ministry yesterday. Greek anarchist group Conspiracy of the Cells of Fire claimed responsibility for yesterday's parcel bomb.

  • In economic data:
    • Eurozone February CPI +0.4% month-over-month, as expected (last -0.8%); +2.0% year-over-year, as expected (last 2.0%). February Core CPI +0.4% month-over-month (last -1.7%); +2.0% year-over-year, as expected (last 2.0%)

---Equity Markets---

  • France's CAC trades up 0.8% with ArcelorMittal jumping 3.0% while financials BNP Paribas, Societe Generale, and Credit Agricole are up between 0.9% and 2.4%. Peugeot and Renault show respective losses of 1.0% and 3.7% as regulators investigate Renault for violating emission standards.
  • Germany's DAX has climbed 1.0% amid broad strength. Lufthansa has spiked 4.0% in reaction to fourth quarter results while Adidas, SAP, BASF, and Siemens rise between 1.0% and 2.3%. Volkswagen, Daimler, and BMW are up between 0.3% and 0.7%.
  • UK's FTSE has added 1.0% with miners and energy names in the lead. Anglo American, Fresnillo, Antofagasta, BHP Billiton, Rio Tinto, Glencore, Royal Dutch Shell, and BP are up between 1.7% and 8.6%. Anglo American is the top performer after Volcan Investments announced a $2.40 billion stake in the miner. Select consumer names lag with Paddy Power, Carnival, British American Tobacco, Sainsbury, Tesco, and Morrison Supermarkets showing losses between 0.3% and 1.1%.
  • Italy's MIB outperforms with a gain of 1.7%. Banca Pop Emilia Romagna, Banco Bpm, UniCredit, FInecoBank, UBI Banca, and Mediobanca have gained between 1.8% and 3.1%.
avatar

Daytrader

 
  Carbonite initiated with a Buy at Craig Hallum; tgt $30  (19.65)
avatar

Daytrader

 
  Sirius XM Radio downgraded to Hold from Buy at Wunderlich  (5.30)
avatar

Daytrader

 
  Duluth Trading Co target lowered to $21 at Stifel  (19.20)Stifel lowers their DLTH tgt to $21 from $33, reiterates Hold. The firm notes that  while they remain encouraged by white space opportunities for the Duluth Trading brand, and are confident in capacity to grow revenue via retail expansion, they believe it is prudent to take a more cautious view on Direct revenue, gross margins, and the multiple. Ahead of 4Q results, they are lowering their previously above consensus estimates for 4Q, 2017, and 2018. 
avatar

Daytrader

 Carpenter Tech upgraded to Buy from Neutral at Seaport Global Securities  (36.55)
avatar

Daytrader

 
  Digital Power discloses the co entered into a subscription agreement for the sale of 500k shares of common stock at $0.60/share for proceeds of $300k in a direct offering  (1.20)
avatar

Daytrader

 
  Allegheny Tech upgraded to Buy from Neutral at Seaport Global Securities  (17.75)
avatar

Daytrader

 
  Overnight Treasury Summary

Treasuries Pull Back as Central Banks Meet

  • U.S. Treasuries are pulling back this morning from very strong post-FOMC gains on Wednesday. Yesterday's decision by the committee to hike rate by 25 basis points was accompanied by a more dovish than expected outlook, with the median FOMC participant forecasting a total of only three rate hikes in 2017. That dovish surprise has gold trading 2.06% higher at $1,225.4/troy oz. and the S&P 500 set to open at 2,388.8, up 0.16% from Wednesday's close but much higher from the index's pre-FOMC level. The U.S. Dollar Index is down by another 0.15% to 100.59 this morning and WTI crude is adding 0.76% to $49.23/bbl. Overnight, there were several rate decisions from central banks and the Bank of England's Monetary Policy Committee will report its decision at 08:00 ET
  • Yield Check:
    • 2-yr: unch at 1.30%
    • 5-yr: +3 bps to 2.03%
    • 10-yr: +3 bps to 2.52%
    • 30-yr: +3 bps to 3.14%
  • Central Bank News:
    • The Bank of Japan kept monetary policy on hold last night, maintaining the main policy rate at -0.10% and the target for the 10-year JGB yield at 0.00%. Asset purchases will remain near JPY80 tln/year
    • The People's Bank of China raised interbank borrowing costs today in the wake of the Federal Reserve's tightening move. The PBoC hiked rates of seven, 14, and 28-day reverse repos by 10 basis points each to 2.45%, 2.30%, and 2.75%, respectively
      • The move was meant to ease downward pressure on the Chinese currency 
    • Turkey's central bank kept its benchmark repo rate at 8.0% but hiked another liquidity facility's rate by 75 basis points to 11.75%, as expected
      • The CBRT's accompanying statement said that policymakers had decided to «strengthen monetary tightening in order to contain the deterioration in the inflation outlook.»
    • Norway's central bank kept its main policy rate on hold at 0.50%, as expected
      • While recognizing that ultra-loose monetary conditions may lead to financial instability, the Norges Bank said that it keep the rate at this level for longer than previously forecast
      • The central bank added that it anticipates that inflation will fall more quickly than previously expected but that «there are prospects that inflation will pick up again further out»
    • The Swiss National Bank kept its deposit rate at -0.75%, as expected, and said that it would remain active to keep a lid on the Swiss franc
  • Economic Data:
    • New Zealand's GDP grew by 0.4% q/q in Q4 (2.7% y/y), missing forecasts and slowing from Q3's 0.8% growth
    • Australian employment fell by 6.4K workers in February, missing estimates for growth after a 13.5K increase in January
    • Eurozone CPI growth for February was confirmed at 0.4% m/m (2.0% y/y), as expected
      • The core CPI was up 0.9% y/y, well below the European Central Bank's 2% target
  • Data out Today:
    • February Housing Starts and Building Permits (08:30 ET)
    • Initial Jobless Claims for the week ending 3/11 and Continuing Jobless Claims for the week ending 3/4 (08:30 ET)
    • March Philadelphia Fed (08:30 ET)
avatar

Daytrader

 S&P futures vs fair value: +4.50. Nasdaq futures vs fair value: +12.90.

The stock market looks poised to continue yesterday's afternoon rally this morning as stocks trade higher around the globe following the latest FOMC rate decision. The S&P 500 futures trade five points, or 0.2%, above fair value.

As expected, the U.S. central bank decided to raise the fed funds target range by 25 basis points to 0.75%-1.00% on Wednesday afternoon. However, the ensuing rally in the equity market was prompted by the Fed's future outlook for interest rates, which turned out to be more dovish than some investors were anticipating. The Fed stuck to its projection for two more rate hikes this year, which is in line with the market's expectation. 

Crude oil looks eager to build on yesterday's bullish momentum this morning as the commodity trades 0.9% higher at $49.27/bbl. The energy component broke a seven session losing streak yesterday after the Energy Information Administration reported an unexpected draw of 200,000 barrels (+3.7 million barrels consensus).

The Treasury market jumped notably higher on Wednesday afternoon following the FOMC decision, but it has given back a portion of those gains this morning. The benchmark 10-yr yield trades three basis points higher at 2.53%.

Today's economic data will include February Housing Starts (Briefing.com consensus 1.260 million), Initial Claims (Briefing.com consensus 242,000), and March Philadelphia Fed (Briefing.com consensus 25.0) at 8:30 ET, while January JOLTS will cross the wires at 10:00 ET.

In U.S. corporate news:

  • Oracle (ORCL 46.01, +2.96): +6.9% after reporting better than expected earnings and providing upbeat earnings guidance. Also of note, the company raised its dividend.
  • Biogen (BIIB 285.00, -7.64): -2.6% after the company's stock was downgraded to 'Equal-Weight' from 'Overweight' at Morgan Stanley. 
  • Dollar General (DG 74.30, +1.49): +2.1% after beating earnings per share estimates.
  • Guess? (GES 10.70, -1.53): -12.5% after missing top and bottom line estimates in addition to issuing disappointing guidance.

Reviewing overnight developments:

  • Equity indices in the Asia-Pacific region ended Thursday on a higher note. Japan's Nikkei +0.1%, Hong Kong's Hang Seng +2.1%, China's Shanghai Composite +0.8%, India's Sensex +0.6%.
    • In economic data:
      • Australia's February Employment Change -6,400 (expected 16,000; last 13,500) and February Unemployment Rate 5.9% (expected 5.7%; last 5.7%). February Participation Rate held at 64.6%, as expected.
      • New Zealand's Q4 GDP +0.4% quarter-over-quarter (expected 0.7%; last 0.8%); +2.7% year-over-year (consensus 3.1%; last 3.3%). Q4 GDP Expenditure +0.2% quarter-over-quarter (expected 0.6%; last 0.9%)
      • Hong Kong's February Unemployment Rate held at 3.3%, as expected
    • In news:
      • The Bank of Japan made no changes to its policy stance, but it did provide upbeat comments about reaching the 2.0% inflation target in the longer run.
      • The People's Bank of China raised its short-term repurchase rates after yesterday's fed funds rate hike from the Federal Reserve.
  • Major European indices trade higher across the board with Italy's MIB showing relative strength. The upbeat disposition comes ahead of the release of the latest policy statement from the Bank of England, which is not expected to upset the current state of affairs. France's CAC +0.8%, Germany's DAX +1.0%, UK's FTSE +1.0%, Italy's MIB +1.7%.
    • In economic data:
      • Eurozone February CPI +0.4% month-over-month, as expected (last -0.8%); +2.0% year-over-year, as expected (last 2.0%). February Core CPI +0.4% month-over-month (last -1.7%); +2.0% year-over-year, as expected (last 2.0%)
    • In news:
      • The Swiss National Bank maintained its key rate at -0.75%, as expected.
      • Dutch Prime Minister Mark Rutte's People's Party for Freedom and Democracy received the most votes, but the party will now have 33 seats in the House of Representatives, down from 41 won in the 2012 election. Geert Wilders' PVV came in second, securing 20 seats.
      • French BFM TV reported that one person was slightly injured in an explosion while opening an envelope at Paris offices of the International Monetary Fund. This comes after a package with explosives was found outside the German finance ministry yesterday. Greek anarchist group Conspiracy of the Cells of Fire claimed responsibility for yesterday's parcel bomb.
avatar

Daytrader

 On The Wires
  • Cellceutix Corporation (CTIX) informs shareholders that, next week, the Company will be providing additional detailed data from its ongoing Phase 2a Proof-of-Concept (PoC) study of Brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD).
  • Klondex Mines (KLDX) disclosed that it has rescheduled its fourth quarter and full year 2016 earnings release and conference call, previously scheduled for Mar 16, 2017, to allow additional time to finalize the accounting adjustments resulting from the initial transition from International Financial Reporting Standards to U.S. Generally Accepted Accounting Principles. Klondex will also reschedule filing its Annual Report on Form 10-K for the fiscal year ended Dec 31, 2016. The revised filing and release date will be Mar 23, 2017. A conference call and webcast will be held the following morning at 10:30 am ET/7:30 am PT.
  • On Mar 10, 2017, the Board of Bellerophon Therapeutics (BLPH) appointed Megan Schoeps as Principal Financial Officer, effective as of Mar 10, 2017. Schoeps has served as the Controller of the co since Feb 2016. Prior to joining the co, Schoeps served as Manager of Financial Reporting at Actavis from Sept 2013 to May 2015.
avatar

Daytrader

 
  Heat Biologics discloses the receipt of a written notice from Nasdaq notifying the co of a continuing listing deficiency related to the failure to maintain the minimum closing bid price of $1.00/share  (0.92)The co intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the NASDAQ listing requirements, including such actions as effecting a reverse stock split to maintain its Nasdaq listing.
avatar

Daytrader

 CareTrust REIT increases quarterly dividend to $0.185/share from $0.17/share  (15.50)
avatar

Daytrader

 
  Oracle: Color on Quarter  (43.05)
  • RBC Capital Mkts raises their ORCL tgt to $47 from $46. Strength in recurring revenue streams and opex control drove the second consecutive quarter of constant currency operating income growth. Cloud bookings were strong and are at least on track for the year. While they expect debate around organic SaaS/ PaaS growth, they see the shape of the income statement improving.
  • BMO: Given inconsistent performance, we believe that Oracle's quarter and guidance, while not spectacular, is enough to push the shares higher. Further, while Oracle has not always delivered against longer-term guidance, we believe that comments that EPS will grow by 10% in FY2018 will generate investor interest in the shares given current valuation. They are making minor adjustments to their estimates, and raising their target to $48 from $45, and retaining their Outperform rating.
  • Wedbush raises tgt to $43 from $42. ORCL's 3Q/Feb. looked better than its 2Q performance, based on their calculations of organic results. As they expected, SaaS and PaaS metrics benefited from the addition of NetSuite, but they also looked better organically. Also, good cost control and an improved tax rate give them reasons to be more positive on the outlook for FY18 EPS growth. However, they remain concerned that consensus expectations for FY18 revenues (about 3% implied organic constant-currency Y/Y) look too high. Although margins could improve next year as optics benefit from the cloud transition, they think they could be pressured longer-term due to a more competitive cloud pricing environment for enterprise applications and database. They would stay on the sidelines.
  • JMP upgrades to Mkt Perofrm
  • JPMorgan upgrades to Overweight
  • ORCL +6% nearing 2 year/all time highs premarket.
avatar

Daytrader

 
  Bioptix discloses on Mar 10 the co sold $2.25 mln units of securities at $2.50/unit, consists of 1 share & a 3-year warrant to purchase 1 share of stock at $3.50/share; on Mar 15 co also agreed to sell up to $4.75 mln promissory notes & 3-year warrants  (3.56)
  • Placement of units:
    • The warrants are exercisable, at any time on or after the sixth month anniversary of the closing date of the private placement, at a price of $3.50 per share, subject to adjustment, and expire three years from the date of issuance. The holders may, subject to certain limitations, exercise the Warrants on a cashless basis. the company is prohibited from effecting an exercise of any warrant to the extent that, as a result of any such exercise, the holder would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock upon exercise of such warrant.
  • Placement of notes:
    • The notes shall be issued to each note investor in such note investor's subscription amount and shall be convertible into shares of common stock at an initial conversion price of $2.50. Each purchase warrant shall be exercisable into shares of common stock at an exercise price equal to $3.56 per share.
avatar

Daytrader

 Gapping up

Gapping up
In reaction to strong earnings/guidance
:

  • XCO +17.2%, GALE +15.3%, PRTO +11.8%, FRSH +11.7%, IDRA +11.5%, ALRM +10.3%, GPRO +10.2%, SKLN +8.2%, ITEK +7.2%
  • JASO +6.6%, CLRB +6.2%, ORCL +6.2%, SAEX +5.8%, MCRB +5.2%, SNOA +4.8%, RMTI +3.6%, CPRX +3.2%, SYNC +3.2%
  • WSM +3.1%, RTK +2.7%, CALL +1.9%, YRD +1.4%, EVOK +1.3%, BTG +1%

M&A news:

  • KGC +1.2% (Confirms that it has received an unsolicited proposal from Virtu Financial (VIRT) for $18.50-$20.00 per share in cash)

Select EU financial related names showing strength:

  • BBVA +4.3%, SAN +4.2%, ING +2.6%, DB +2.3%, CS +1.8%

Select metals/mining stocks trading higher:

  • SWC +2.7%, AG +2.6%, BBL +1.8%, FCX +1.6%, BHP +1.5%, VALE +1.5%
  • SSRI +1.4%, PAAS +1.4%, CLF +1.3%, GOLD +1%, AEM +1%

Other news:

  • HTBX +13% (receivse a 3 year, $982k grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test gp96-based Zika vaccine)
  • MCRB +5.2% (Seres Therapeutics and FDA reach agreement on key design elements of a new SER-109 Phase 2 study)
  • CTSO +3.9% (enters into a partnership with Dr. Reddy's Laboratories (RDY) for the South African market)
  • TLND +3.2% (upsizes and prices offering by selling shareholders of 3,289,662 ADSs at $28.50 per share)
  • TSLA +3% (Announces offerings of $250 mln of common stock and $750 mln aggregate principal amount of convertible senior notes due in 2022 in concurrent underwritten registered public offerings)
  • DO +2.3% (Updates on injunction vs. Petrobras (PBR) regarding the Ocean Valor)
  • EXK +2.3% (announces that exploration drilling on the Terronera property)
  • AMRN +2.2% (reports REDUCE-IT Cardiovascular outcomes study remains on schedule to reach onset of target final primary major adverse cardiovascular event near the end of 2017)
  • BKS +1.7% (Board authorizes new stock repurchase program of up to $50 mln of its common shares)
  • SPWR +1.7% (Enters into a Project Supply Agreement with Next Era Energy Resources
  • SAP +1.4% (in sympathy with ORCL earnings)
  • EQC +1.3% (Board adds $150 mln to buyback program)

Analyst comments:

  • LC +3.2% (upgraded to Buy from Neutral at Guggenheim)
  • GBT +2.6% (Initiated with an Overweight at Cantor)
  • ABX +1.6% (upgraded to Outperform at RBC Capital Mkts)
  • GG +1.6% (upgraded to Sector Perform at RBC Capital Mkts)
  • DAL +1.3% (upgraded to Outperform from In Line at Evercore ISI)
  • LITE +1.2% (upgraded to Neutral from Sell at Goldman)
avatar

Daytrader

 
  On The Wires
  • InterCloud Systems (ICLD) announced that it was recently awarded over $1.6 mln in new contracts to provide next-generation Wi-Fi and DAS network upgrades. A majority of the work is expected to begin immediately.
  • eBay Advertising, a division of eBay (EBAY), announced a shift in its advertising strategy to focus on first-party data and offerings that will help brands drive commerce on the core eBay Marketplace. As part of this strategy, eBay Advertising is building a direct ad sales team for the first time, focused on developing commerce partnerships with global brands to reach buyers at every stage of the shopping journey. The company is also announcing a record 48% increase in the number of advertising customers acquired in 2016. eBay Advertising is working with the world's largest auto, consumer electronics, fashion, health & beauty and home & garden brands.
  • Effective as of Mar 16, 2017, the Board of Biostage (BSTG) appointed Saverio LaFrancesca, M.D., the co's Chief Medical Officer, as President of the co. Dr. LaFrancesca will also continue to serve as the co's Chief Medical Officer. James McGorry, who had served as the co's President prior to the effective date, will continue to serve as CEO & principal executive officer.
  • Epsilon, an Alliance Data (ADS) co, announced it has signed a new agreement with Harvest Hill Beverage Co to provide experiential event services for Juicy Juice Splashers and its title sponsorship of the KIDZ BOP Best Time Ever national tour.
  • Abiomed (ABMD) announced that there are more than 10 presentations, including a late-breaking clinical research presentation, featuring the Impella line of heart pumps, in addition to 17 poster presentations scheduled during the American College of Cardiology's 66th Annual Scientific Session, March 17-19 at the Walter E. Washington Convention Center in Washington, DC.
  • Intellipharmaceutics International (IPCI) disclosed that effective at the opening of trading on Mar 20, 2017 common shares of the co will commence trading on the Toronto Stock Exchange under the symbol «IPCI».
avatar

Daytrader

 Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • GES -13.6%, ARTX -13.4%, TROV -8.6%, INO -6.8%, PLX -6.3%, CNAT -5.3%, CVRS -2.9%, INSY -2.8%
  • KPTI -2.7%, TTNP -2.5%, BCEI -1.7%, GV -1.7%, KNDI -1.2%

Other news:

  • IPI -12% (prices a 43.54 mln share underwritten public offering of common stock for gross proceeds of about $52.3 mln)
  • AVID -6.5% (Postpones conference call to discuss Q4 financial results)
  • PEN -4.1% (Commences an underwritten public offering of 1.3 mln shares of its common stock)
  • ELF -1.3% (Files for $175 mln offering of common stock by selling stockholders)

Analyst comments:

  • BIIB -2.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • CIEN -1.6% (downgraded to Neutral from Buy at Goldman; removed from Conviction Buy List)
  • SIRI -1.5% (downgraded to Hold from Buy at Wunderlich)
  • MASI -1.2% (downgraded to Neutral from Overweight at Piper Jaffray)
  • UTHR -1% (initiated with a Underperform at Credit Suisse)
avatar

Daytrader

 
  Overseas Research Calls

Upgrades

  • Norsk Hydro (NHYDY) upgraded to Overweight from Neutral at JP Morgan
  • Intertek Group (IKTSY) upgraded to Buy from Hold at Deutsche Bank
  • Empire Co. (EMLAF) upgraded to Equal Weight from Underweight at Barclays
  • Tullow Oil plc (TUWLF) upgraded to Hold from Sell at Panmure
  • Amec Foster Wheeler (AMFW) upgraded to Neutral from Underperform at Exane BNP Paribas

Downgrades

  • Hikma (HKMPF) downgraded to Neutral from Overweight at JP Morgan
  • John Wood Group plc (WDGJF) downgraded to Neutral from Outperform at Exane BNP Paribas

Miscellaneous

  • Premier Oil plc (PMOIY) initiated with a Buy at Peel Hunt
  • DevroPLC (DEVOY) resumed with a Hold at N+1
avatar

Daytrader

 
  Quest Diagnostics upgraded to Neutral from Underperform at BofA/Merrill  (99.74)
avatar

Daytrader

 
  S&P futures vs fair value: +3.50. Nasdaq futures vs fair value: +9.40.

The S&P 500 futures trade four points above fair value.

Housing starts increased to a seasonally adjusted annualized rate of 1.288 million units in February, up from a revised 1.251 million units in January (from 1.246 million). The Briefing.com consensus expected starts to increase to 1.260 million units. Building permits decreased to a seasonally adjusted 1.213 million in February from a revised 1.293 million (from 1.285 million) for January. The Briefing.com consensus expected a reading of 1.251 million.

The latest weekly initial jobless claims count totaled 241,000 while the Briefing.com consensus expected a reading of 242,000. Today's tally was below the unrevised prior week count of 243,000. As for continuing claims, they declined to 2.030 million from the revised count of 2.060 million (from 2.058 million).

The Philadelphia Fed Survey for March declined to 32.8 from an unrevised 43.3 in February while economists polled by Briefing.com had expected a reading of 25.0.

avatar

Daytrader

 Gapping up/down: XCO +17%, GPRO +10%, JASO +7% and ORCL +6% after earnings/guidance, TSLA +3% after offerings; GES -14% and KNDI -1% after earnings, BIIB -2% after dg at MS

Gapping up
In reaction to strong earnings/guidance
:

  • XCO +17.2%, GALE +15.3%, PRTO +11.8%, FRSH +11.7%, IDRA +11.5%, ALRM +10.3%, GPRO +10.2%, SKLN +8.2%, ITEK +7.2%
  • JASO +6.6%, CLRB +6.2%, ORCL +6.2%, SAEX +5.8%, MCRB +5.2%, SNOA +4.8%, RMTI +3.6%, CPRX +3.2%, SYNC +3.2%
  • WSM +3.1%, RTK +2.7%, CALL +1.9%, YRD +1.4%, EVOK +1.3%, BTG +1%

M&A news:

  • KGC +1.2% (Confirms that it has received an unsolicited proposal from Virtu Financial (VIRT) for $18.50-$20.00 per share in cash)

Select EU financial related names showing strength:

  • BBVA +4.3%, SAN +4.2%, ING +2.6%, DB +2.3%, CS +1.8%

Select metals/mining stocks trading higher:

  • SWC +2.7%, AG +2.6%, BBL +1.8%, FCX +1.6%, BHP +1.5%, VALE +1.5%
  • SSRI +1.4%, PAAS +1.4%, CLF +1.3%, GOLD +1%, AEM +1%

Other news:

  • HTBX +13% (receivse a 3 year, $982k grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test gp96-based Zika vaccine)
  • MCRB +5.2% (Seres Therapeutics and FDA reach agreement on key design elements of a new SER-109 Phase 2 study)
  • CTSO +3.9% (enters into a partnership with Dr. Reddy's Laboratories (RDY) for the South African market)
  • TLND +3.2% (upsizes and prices offering by selling shareholders of 3,289,662 ADSs at $28.50 per share)
  • TSLA +3% (Announces offerings of $250 mln of common stock and $750 mln aggregate principal amount of convertible senior notes due in 2022 in concurrent underwritten registered public offerings)
  • DO +2.3% (Updates on injunction vs. Petrobras (PBR) regarding the Ocean Valor)
  • EXK +2.3% (announces that exploration drilling on the Terronera property)
  • AMRN +2.2% (reports REDUCE-IT Cardiovascular outcomes study remains on schedule to reach onset of target final primary major adverse cardiovascular event near the end of 2017)
  • BKS +1.7% (Board authorizes new stock repurchase program of up to $50 mln of its common shares)
  • SPWR +1.7% (Enters into a Project Supply Agreement with Next Era Energy Resources
  • SAP +1.4% (in sympathy with ORCL earnings)
  • EQC +1.3% (Board adds $150 mln to buyback program)

Analyst comments:

  • LC +3.2% (upgraded to Buy from Neutral at Guggenheim)
  • GBT +2.6% (Initiated with an Overweight at Cantor)
  • ABX +1.6% (upgraded to Outperform at RBC Capital Mkts)
  • GG +1.6% (upgraded to Sector Perform at RBC Capital Mkts)
  • DAL +1.3% (upgraded to Outperform from In Line at Evercore ISI)
  • LITE +1.2% (upgraded to Neutral from Sell at Goldman)

Gapping down
In reaction to disappointing earnings/guidance
:

  • GES -13.6%, ARTX -13.4%, TROV -8.6%, INO -6.8%, PLX -6.3%, CNAT -5.3%, CVRS -2.9%, INSY -2.8%
  • KPTI -2.7%, TTNP -2.5%, BCEI -1.7%, GV -1.7%, KNDI -1.2%

Other news:

  • IPI -12% (prices a 43.54 mln share underwritten public offering of common stock for gross proceeds of about $52.3 mln)
  • AVID -6.5% (Postpones conference call to discuss Q4 financial results)
  • PEN -4.1% (Commences an underwritten public offering of 1.3 mln shares of its common stock)
  • ELF -1.3% (Files for $175 mln offering of common stock by selling stockholders)

Analyst comments:

  • BIIB -2.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • CIEN -1.6% (downgraded to Neutral from Buy at Goldman; removed from Conviction Buy List)
  • SIRI -1.5% (downgraded to Hold from Buy at Wunderlich)
  • MASI -1.2% (downgraded to Neutral from Overweight at Piper Jaffray)
  • UTHR -1% (initiated with a Underperform at Credit Suisse)
avatar

Daytrader

 
  Kadmon Holdings upgraded to Hold at WBB Securities; tgt $3.25 — Completes private equity offer of ~$23 mln  (3.48)WBB Securities upgrades KDMN to Hold from Sell and sets target price at $3.25. Firm updates their coverage based on the current price of KDMN, its current rev, its clinical path progress and our general unease of these capital markets. Firm's assumptions use 52.00 million shares with a model that uses a simple sum of the parts that assigns a $1.25 for the current revenue programs, $1.00 for the development platform and a $1.00 value for current cash. 
avatar

Daytrader

 Franklin Resources upgraded to Buy from Neutral at BofA/Merrill  (42.99)
avatar

Daytrader

 European Summary

Bank of England Stays Put but Pound and Gilt Yields Jump

  • European sovereign bonds are trading lower today in the wake of a flood of central bank rate decisions. The Bank of England, Swiss National Bank, Norges Bank, and Turkey's central bank all released monetary policy decisions this morning. There were no big surprises but the British pound and gilt yields are moving higher as «some members» of the BoE's Monetary Policy Committee said that it would take relatively little in the way of upside surprises on inflation or output data for them to weigh an immediate tightening move. It is notable that sovereign debt in the eurozone did not rally in sympathy with the move in Treasuries following Wednesday's dovish surprise from the Federal Reserve. Yields at the 10-year tenor in France, Germany, Italy, and Spain remain roughly five basis points away from their 52-week highs
    • GBP/USD: +0.46% to 1.2357
  • Economic Data:
    • Eurozone CPI growth for February was confirmed at 0.4% m/m (2.0% y/y), as expected
    • The core CPI was up 0.9% y/y, well below the European Central Bank's 2% target
  • New Issuance:
    • France sold EUR3.975 bln of 3-year BTANs with an average yield of -0.29% and a bid-to-cover of 1.68
    • France sold EUR2.104 bln of 5-year BTANs with an average yield of 0.18% and a bid-to-cover of 2.06
    • Spain sold EUR1.668 bln of 5-year Bonos with an average yield of 0.548% and a bid-to-cover of 1.45
    • Spain sold EUR1.394bln of 10-year ODEs (9y 7m) with an average yield of 1.682% and a bid-to-cover of 1.56
    • Spain sold EUR1.075 bln of 10-year ODEs (11y 7m) with an average yield of 1.935% and a bid-to-cover of 1.33
    • Spain sold EUR674 mln of 30-year ODEs with an average yield of 2.688% and a bid-to-cover of 1.56
  • Yield Check:
    • France, 10-yr OAT: +6 bps to 1.09%
    • Germany, 10-yr bund: unch at 0.45%
    • Greece, 10-yr note: unch at 7.23%
    • Italy, 10-yr BTP: +6 bps to 2.35% 
    • Portugal, 10-yr PGB: -2 bps to 3.96%
    • Spain, 10-yr ODE: +7 bps to 1.88%
    • U.K., 10-yr gilt: +6 bps to 1.27%
avatar

Daytrader

 
  Camtek: Yelin Lapidot Holdings Management discloses a 5.03% passive stake  (3.95)
avatar

Daytrader

 Fiat Chrysler reports sales in Europe increased 8.7% YoY  (11.32)
  • In February, sales in Europe were up 8.7% year-over-year, once again outperforming the industry which registered an average increase of 2.1%.
  • As a result, FCAU's European market share increased to 7.9% (from 7.4%)
avatar

Daytrader

 
  Primo Water target raised to $20 at Lake Street  (14.98)Lake Street raises their PRMW tgt to $20 from $16.50. Firm noted company results and guidance in-line with previously provided results and outlook provided during its modeling call for its acquisition of Glacier which was held back in January. They don't change their ests but suggests that the integration of Glacier appears to be on-track to slightly ahead and additional synergies exist that are not in the ests and guidance. Co added another 5-year extension to its deal with DS Services for exchange services. Firm ups tgt based on 15x FY'18 EV/EBITDA as the company is hitting its stride and Glacier acquisition appears on track.
avatar

Daytrader

FB
avatar

sereja К

 не понимаю как рынок умеет это но снова всё мылиться на бай…
avatar

sereja К

 психологически не могу баить хоть убей…
avatar

sereja К

  с провалов баить могу, а вот так вот хаи баить постоянно…
avatar

sereja К

я тож торгую только шорты)
 кстати на Европе, отлично идут от локальных хаев
 с середины дня, все скатываются
 AAPL
avatar

sereja К

ATH
avatar

sereja К

FB сильнее рынка
avatar

sereja К

 NVDA
avatar

sereja К

EOG уровень 95,90
avatar

sereja К

 VEEV
avatar

sereja К

 NUE
avatar

sereja К


Только зарегистрированные и авторизованные пользователи могут оставлять комментарии.

Залогиниться

Зарегистрироваться
....все тэги
Регистрация
UPDONW